Ken Griffin Cabaletta Bio, Inc. Transaction History

Citadel Advisors LLC

$550 Billion
Q2 2025

A detailed history of Ken Griffin (Citadel Advisors LLC) transactions in Cabaletta Bio, Inc. stock. As of the latest transaction made, Citadel Advisors LLC holds 1,687,980 shares of CABA stock, worth $2.25 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

1,687,980

Previous 40,500 4067.85%

Holding current value

$2.25 Million

Previous $56,000 4480.36%

% of portfolio

0.0%

Previous 0.0%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 14, 2025	BUY	$1.04 - $2.48 $1.76 Million - $4.19 Million	1,687,630 Added 482180.0%	1,687,980 $2.57 Million
Q1 2025 May 15, 2025	BUY	$1.39 - $2.74 $486 - $959	350 New	350 $0
Q3 2024 Nov 14, 2024	SELL	$3.94 - $8.24 $1.24 Million - $2.6 Million	-315,035 Reduced 98.59%	4,511 $21,000
Q2 2024 Aug 14, 2024	BUY	$7.22 - $18.82 $2.29 Million - $5.97 Million	317,305 Added 14159.08%	319,546 $2.39 Million
Q1 2024 May 15, 2024	SELL	$16.79 - $25.38 $531,218 - $802,997	-31,639 Reduced 93.39%	2,241 $38,000
Q4 2023 Feb 14, 2024	BUY	$12.21 - $23.36 $383,601 - $733,901	31,417 Added 1275.56%	33,880 $769,000
Q3 2023 Nov 14, 2023	BUY	$11.84 - $18.65 $29,161 - $45,934	2,463 New	2,463 $37,000
Q1 2023 May 15, 2023	SELL	$7.08 - $12.62 $368,025 - $656,000	-51,981 Reduced 71.03%	21,197 $175,000
Q4 2022 Feb 14, 2023	BUY	$0.64 - $9.3 $46,833 - $680,555	73,178 New	73,178 $676,000
Q2 2022 Aug 15, 2022	SELL	$0.99 - $2.11 $218,414 - $465,510	-220,621 Reduced 14.96%	1,254,479 $1.33 Million
Q1 2022 May 16, 2022	SELL	$1.68 - $3.92 $41,198 - $96,130	-24,523 Reduced 1.64%	1,475,100 $2.99 Million
Q4 2021 Feb 14, 2022	BUY	$3.36 - $14.64 $3.16 Million - $13.8 Million	940,156 Added 168.04%	1,499,623 $5.68 Million
Q3 2021 Nov 15, 2021	BUY	$7.0 - $12.5 $3.65 Million - $6.53 Million	522,135 Added 1398.63%	559,467 $6.8 Million
Q2 2021 Aug 16, 2021	BUY	$7.2 - $11.73 $133,063 - $216,782	18,481 Added 98.04%	37,332 $321,000
Q1 2021 May 17, 2021	BUY	$10.39 - $14.53 $83,556 - $116,850	8,042 Added 74.4%	18,851 $209,000
Q4 2020 Feb 16, 2021	BUY	$9.81 - $15.8 $106,036 - $170,782	10,809 New	10,809 $135,000
Q2 2020 Aug 14, 2020	SELL	$6.39 - $11.28 $104,233 - $183,999	-16,312 Closed	0 $0
Q1 2020 May 15, 2020	BUY	$6.0 - $18.67 $97,872 - $304,545	16,312 New	16,312 $119,000

Others Institutions Holding CABA

# of Institutions

Shares Held

77M

Call Options Held

406K

Put Options Held

90.9K

View Full List

About Cabaletta Bio, Inc.

Ticker CABA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 29,014,000
Market Cap $38.6M
Description
Cabaletta Bio, Inc., a clinical-stage biotechnology company, focuses on the discovery and development of engineered T cell therapies for patients with B cell-mediated autoimmune diseases. Its proprietary technology utilizes chimeric autoantibody receptor (CAAR) T cells that are designed to selectively bind and eliminate B cells, which produce di...

More about CABA

Track Ken Griffin's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Citadel Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Citadel Advisors LLC and Ken Griffin with notifications on news.

Account